Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

NCT01164501 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

741

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Renal Insufficiency

Interventions

DRUG: BI 10773
DRUG: Placebo
DRUG: Placebo
DRUG: BI 10773
DRUG: Placebo
DRUG: Placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]